Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery
about
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@en
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@nl
type
label
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@en
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@nl
prefLabel
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@en
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@nl
P2093
P2860
P356
P1476
Ischemic and bleeding outcomes ...... d clopidogrel prior to surgery
@en
P2093
Aun-Yeong Chong
Benjamin Hibbert
CArdiovascular Percutaneous Intervention TriAL (CAPITAL) investigators
Daniel Goubran
Derek Yf So
Diem Tt Tran
Fraser Rubens
George A Wells
Jean-Francois Tanguay
Jean-Yves Dupuis
P2860
P304
2048872617740832
P356
10.1177/2048872617740832
P577
2018-01-01T00:00:00Z